Boston Heart Diagnostics CEO Susan Hertzberg Named Ernst & Young Entrepreneur Of The Year® 2013 Finalist in New England

FRAMINGHAM, Mass., June 20, 2013 /PRNewswire/ -- Boston Heart Diagnostics, a pioneer in integrating next-generation diagnostics into personalized nutrition and lifestyle programs for patients with or at risk for heart disease, announced that a panel of independent judges has selected its President and CEO, Susan Hertzberg, as a finalist for the Ernst & Young Entrepreneur Of The Year 2013 Award in the New England Region. The awards program, one of the most prestigious business awards for entrepreneurs, recognizes high-growth entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities. Award winners will be announced at a special gala event on Wednesday, June 26, 2013 at the Renaissance Waterfront in Boston.

"Susan Hertzberg's strategic vision, operational know-how, and inspirational leadership have made her a change agent at Boston Heart, where she has instilled results-driven discipline and a focus on delivering innovative products and services that put patients first and delight customers every time," said Boston Heart's Chairman, Peter D. Parker. "When she joined in 2010, the company was a start-up, well respected in the medical and scientific communities, with promising technology and prospects. Boston Heart is now a leader in its field, reinventing diagnostics with actionable information and tailor-made strategies for patients and clinicians to drive positive health outcomes. Boston Heart's culture is one of inclusiveness, trust, respect, and fun – where employees are excited to come to work every day and are passionate about improving the lives of patients. The results speak for themselves. Susan and her team have propelled the company to extraordinary success, not just in terms of financial performance – but also in engaging patients in their own health to help reduce cardiovascular risk."

Boston Heart continues to grow in stature and reputation. In addition to this latest honor for Hertzberg, in 2012, the Boston Globe named Boston Heart one of the "Top Places to Work" and the company was a "Rising Star" winner for the Team Massachusetts Economic Impact Awards, which celebrates companies that make outstanding contributions to the Commonwealth's economy.

Now in its 27th year, the Ernst & Young Entrepreneur Of The Year Program has expanded globally to recognize company builders in more than 140 cities and in more than 50 countries throughout the world. Regional award winners go on to compete at the national level. Award winners in several national categories, as well as the National Ernst & Young Entrepreneur Of The Year Overall Award winner, will be announced at the annual awards gala in Palm Springs, California, on November 16, 2013.

About Boston Heart Diagnostics (BostonHeartDiagnostics.com)
Boston Heart is re-inventing the role of diagnostics in cardiovascular disease (CVD), the number one cause of death in the United States. There's much more to CVD than "good" and "bad" cholesterol – that's why traditional cholesterol screens often miss those at significant risk for heart attack or stroke. In fact, individuals can still have up to a 75% residual risk for serious cardiac events after successfully lowering LDL. We work with healthcare providers to engage individuals in their own well-being and give them the tools they need to prevent or reduce their CVD risk and improve health outcomes. Applying the latest clinical research and advances in laboratory science, we integrate results from our proprietary tests and health history information with an individual's food and exercise preferences – all transformed into practical nutrition, lifestyle, and support strategies tailor-made for each person. We help people make meaningful and lasting change through the use of easy-to-understand reports, one-on-one coaching, and sustained support. Boston Heart Diagnostics is leading the charge to turn the promise of personalized medicine into a reality.

Media contact: Caroline Grossman - 781.771.5579 - [email protected]

SOURCE Boston Heart Diagnostics